Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (596)	6/30/2000 7:52:16 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 1834

His timing with NBIX was not as good as ours: 3/31/00 467,400 $9.93 2.1 386,100 474.9 12/31/99 81,300 0.4 13,200 19.4 He was heavy buyer in 2 Q, ~600K shares. However, it doesn't mean that he will not do well in coming years. He probably sold small part (of the higher cost) in recent bobble (R2000 effects, as Peter will say). Miljenko

To: scaram(o)uche who wrote (596)	7/1/2000 9:20:12 PM
From: tom pope	Read Replies (1) \| Respond to of 1834

A couple of stocks I follow had crazy patterns today, including NBIX. I was wondering whether the action might be connected with this (from TheStreet.com) >>[Russell 2000]mayhem in a ton of biotechs between $300-$1 billion market caps. Many ramped up because they were going to be included. I saw a few ramp on the rumor of being included and were then dropped like a hot potato around mid-day when it was learned that they wouldn't be included. So many of these stocks are too thinly traded to handle this... swings of 20% up to 20% down on a dime. Creates many opportunities for the swift. << REGN was also crazy on Friday, among others. Might the action in NBIX have been Russell 2000 related? Did a search but found no news on any additions Friday or even current compostion of the Russell 2k.